Header cover image

French Pharmaceuticals & Biotech Breakout Stocks

Results

1

1 new

Stocks where the price continues to rise after more than a year of consistent gains.

1 companies

ABIVAX Société Anonyme

Market Cap: €9.2b

A clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.

New

ABVX

€115.50

7D

34.9%

1Y

1,650.0%